
About Reliance Chemotex
Reliance Chemotex is a publicly listed company based in Mumbai (India) founded in 1977. Reliance Chemotex is engaged in manufacturing synthetic yarns for textiles. It operates on a Reseller / Distribution model. The company has 2,420 employees. Its Indian entity Reliance Chemotex Industries Ltd reported revenue of βΉ366 Cr. Reliance Chemotex offers products and services including Synthetic Yarns. Its focus areas include Textiles, Yarn Manufacturing and Synthetic Yarns. Similar companies include Gokaldas Exports, Eastman Exports and Shahi; 2 of its 3 listed similar companies have raised funding.
Company details
Reliance Chemotex is involved in the production of synthetic ecru and dyed yarns, catering to a wide range of textile industries globally. The companys products are utilized in applications such as carpets, awnings, artificial leather, and suitings. With exports to over 37 countries, operations are focused on quality and customer-centric solutions. The sector primarily served is textiles, with an emphasis on versatility and innovation in yarn manufacturing.
- Headquarters Mumbai, India
- Employees 2,420
- Stage Public
- SectorsIndustrial Goods & Manufacturing
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website reliancechemotex.com
- Legal Name Reliance Chemotex Industries Ltd
- Market Cap₹89.57 Cr
RELCHEMQ · NSE
- Share Price₹120.88
+1.80% today
- Revenue₹362 Cr
FY 2025-26 · +1.0% YoY
- EBITDA₹40.70 Cr
Margin 11.2%
- Net Profit₹4.94 Cr
FY 2025-26 · +32.8% YoY
- P/E (TTM)10.8x
P/B 0.6x
- ROE3.8%
ROCE 7.1%
- Debt / Equity1.89
Interest cover 96.1x
- Employee Count2,420
Associated legal entities of Reliance Chemotex
Reliance Chemotex operates through Reliance Chemotex Industries Ltd, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Reliance Chemotex Industries Ltd Listed CIN L40102RJ1977PLC001994 | Active | 23 Aug 1977 | Udaipur, Rajasthan | ₹366 Cr | 8 | View details |
Products & Services of Reliance Chemotex
Reliance Chemotex offers a comprehensive portfolio of products and services, including Synthetic Yarns.
Synthetic yarns are produced for diverse textile applications.
Board of directors of Reliance Chemotex Industries Ltd (Reliance Chemotex)
Reliance Chemotex Industries Ltd is the primary company behind Reliance Chemotex. The board of Reliance Chemotex Industries Ltd currently have 7 directors; the longest-serving is Sanjiv Shroff, appointed in 1988. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Shroff DIN 00296008 | Managing Director | 01 Sep 1988 | 38 yrs 2 mo | Reliance Chemotex Industries Ltd |
| Ameya Shroff DIN 05315616 | Whole-time director | 29 Jun 2013 | 13 yrs 4 mo | Reliance Chemotex Industries Ltd |
| Rahul Shroff DIN 02301693 | Whole-time director | 26 Sep 2015 | 11 yrs 1 mo | Reliance Chemotex Industries Ltd |
| Ram Niwas Sharma DIN 00368947 | Director | 09 Apr 2016 | 10 yrs 7 mo | Reliance Chemotex Industries Ltd |
| Vijay Kumar Nagar DIN 10552319 | Director | 01 Apr 2024 | 2 yrs 7 mo | Reliance Chemotex Industries Ltd |
| Amit Sushilkumar Saboo DIN 05311484 | Director | 01 Apr 2024 | 2 yrs 7 mo | Reliance Chemotex Industries Ltd |
| Sruthy Sreerag Nath DIN 10479724 | Director | 01 Apr 2024 | 2 yrs 7 mo | Reliance Chemotex Industries Ltd |
People of Reliance Chemotex
1 people are tracked at Reliance Chemotex (1 in leadership); the tracked headcount is 2,420.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Reliance Chemotex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Reliance Chemotex
Reliance Chemotex is a publicly listed company on the NSE with ticker symbol RELCHEMQ in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 May 2022
- Listed onNSE: RELCHEMQ
- Listed entityReliance Chemotex Industries Ltd
- Exchange sectorProcess industries
- ISININE750D01016
- Share price₹112.02 (+0.02% on the day) · 2026-10-14
- Market capitalisation₹84.5 Cr
- Price to earnings15.2
- EPS (diluted, trailing year)₹7.38
- Dividend yield0.45%
- Volume (last session)764
Financials of Reliance Chemotex
Exchange-reported figures of Reliance Chemotex Industries Ltd, the listed company behind Reliance Chemotex (NSE: RELCHEMQ).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 362 | 359 | 367 | 365 | 362 | 256 | 300 |
| Revenue growth | +1.0% | -2.3% | +0.6% | +0.9% | +41.5% | -14.7% | - |
| EBITDA | 40.70 | 32.26 | 31.04 | 34.24 | 41.43 | 23.11 | 28.37 |
| EBITDA margin | +11.2% | +9.0% | +8.5% | +9.4% | +11.5% | +9.0% | +9.5% |
| Profit before tax | 4.84 | 3.65 | 5.61 | 16.71 | 27.34 | 10.35 | 10.76 |
| Net profit | 4.94 | 3.72 | 3.20 | 12.74 | 20.60 | 7.02 | 9.28 |
| Net profit margin | +1.4% | +1.0% | +0.9% | +3.5% | +5.7% | +2.8% | +3.1% |
| EPS (βΉ) | 6.96 | 5.35 | 4.25 | 16.43 | 23.99 | 9.17 | 12.34 |
| Balance sheet | |||||||
| Total assets | 436 | 401 | 418 | 334 | 252 | 202 | 165 |
| Net worth | 143 | 137 | 134 | 132 | 121 | 104 | 98.13 |
| Total debt | 268 | 263 | 281 | 199 | 128 | 97.36 | 64.67 |
| Cash & bank | 12.85 | 11.40 | 50.59 | 61.54 | 57.80 | 32.56 | 5.04 |
| Net working capital | 133 | 108 | 122 | 111 | 75.15 | 65.74 | 31.42 |
| Cash flow | |||||||
| Cash from operations | 21.65 | 10.81 | 17.95 | (0.04) | 59.37 | 27.16 | 21.56 |
| Cash from investing | (1.85) | 32.88 | (81.53) | (50.68) | (73.55) | (42.86) | (7.54) |
| Cash from financing | (19.97) | (43.38) | 59.81 | 54.69 | 13.93 | 15.25 | (13.37) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 119 | 98.82 | 88.18 | 81.94 | 99.52 | 92.36 | 82.20 | 92.23 |
| Revenue growth (YoY) | +19.4% | +7.0% | +7.3% | -11.2% | +8.7% | -0.2% | - | - |
| Other income | 0.81 | 0.90 | 2.68 | 0.40 | 0.36 | 0.39 | 1.72 | 0.56 |
| Total expenses | 105 | 88.02 | 79.20 | 71.24 | 89.25 | 81.61 | 70.84 | 83.27 |
| EBITDA | 13.82 | 10.80 | 8.98 | 10.70 | 10.27 | 10.75 | 11.36 | 8.96 |
| EBITDA margin | +11.6% | +10.9% | +10.2% | +13.1% | +10.3% | +11.6% | +13.8% | +9.7% |
| Depreciation | 3.70 | 3.63 | 3.70 | 3.70 | 3.70 | 3.69 | 4.22 | 3.50 |
| Interest | 6.78 | 6.76 | 6.21 | 6.32 | 5.88 | 6.50 | 5.83 | 5.91 |
| Profit before tax | 4.15 | 1.31 | 1.75 | 1.08 | 1.05 | 0.95 | 3.03 | 0.11 |
| Tax | (0.42) | (0.07) | (0.01) | 0.28 | (0.59) | (0.11) | 1.18 | (0.07) |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 119 | 98.82 | 88.18 | 81.94 | 99.52 | 92.36 | 82.20 | 92.23 |
| Revenue growth (YoY) | +19.4% | +7.0% | +7.3% | -11.2% | +8.7% | -0.2% | - | - |
| Other income | 0.81 | 0.90 | 2.68 | 0.40 | 0.36 | 0.39 | 1.72 | 0.56 |
| Total expenses | 105 | 88.02 | 79.20 | 71.24 | 89.25 | 81.61 | 70.84 | 83.27 |
| EBITDA | 13.82 | 10.80 | 8.98 | 10.70 | 10.27 | 10.75 | 11.36 | 8.96 |
| EBITDA margin | +11.6% | +10.9% | +10.2% | +13.1% | +10.3% | +11.6% | +13.8% | +9.7% |
| Depreciation | 3.70 | 3.63 | 3.70 | 3.70 | 3.70 | 3.69 | 4.22 | 3.50 |
| Interest | 6.78 | 6.76 | 6.21 | 6.32 | 5.88 | 6.50 | 5.83 | 5.91 |
| Profit before tax | 4.15 | 1.31 | 1.75 | 1.08 | 1.05 | 0.95 | 3.03 | 0.11 |
| Tax | (0.42) | (0.07) | (0.01) | 0.28 | (0.59) | (0.11) | 1.18 | (0.07) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 362 | 359 | 367 | 365 | 362 | 256 | 300 |
| Revenue growth | +1.0% | -2.3% | +0.6% | +0.9% | +41.5% | -14.7% | - |
| Other income | 3.83 | 10.17 | 4.27 | 6.16 | 6.59 | 4.49 | 1.06 |
| Total expenses | 321 | 326 | 336 | 331 | 320 | 233 | 271 |
| Employee cost | 67.75 | 66.70 | 57.85 | 51.09 | 47.11 | 42.35 | 39.38 |
| EBITDA | 40.70 | 32.26 | 31.04 | 34.24 | 41.43 | 23.11 | 28.37 |
| EBITDA margin | +11.2% | +9.0% | +8.5% | +9.4% | +11.5% | +9.0% | +9.5% |
| Depreciation | 14.79 | 14.67 | 10.13 | 9.76 | 8.53 | 7.60 | 7.34 |
| Interest | 24.90 | 24.11 | 19.57 | 13.93 | 12.15 | 9.65 | 11.33 |
| Profit before tax | 4.84 | 3.65 | 5.61 | 16.71 | 27.34 | 10.35 | 10.76 |
| Tax | (0.42) | (0.39) | 2.41 | 4.29 | 9.22 | 3.43 | 1.44 |
| Net profit | 4.94 | 3.72 | 3.20 | 12.74 | 20.60 | 7.02 | 9.28 |
| Net profit margin | +1.4% | +1.0% | +0.9% | +3.5% | +5.7% | +2.8% | +3.1% |
| EPS (βΉ) | 6.96 | 5.35 | 4.25 | 16.43 | 23.99 | 9.17 | 12.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 7.56 | 7.56 | 7.56 | 7.56 | 7.56 | 7.56 | 7.56 |
| Reserves & surplus | 135 | 130 | 126 | 124 | 114 | 96.83 | 90.57 |
| Shareholders' funds (net worth) | 143 | 137 | 134 | 132 | 121 | 104 | 98.13 |
| Secured loans | 149 | 156 | 184 | 108 | 57.50 | 45.49 | 33.19 |
| Unsecured loans | 119 | 107 | 96.59 | 90.95 | 70.46 | 51.87 | 31.48 |
| Total debt | 268 | 263 | 281 | 199 | 128 | 97.36 | 64.67 |
| Total liabilities | 436 | 401 | 418 | 334 | 252 | 202 | 165 |
| Assets | |||||||
| Gross block | 383 | 382 | 367 | 237 | 213 | 175 | 160 |
| Net block | 299 | 313 | 318 | 196 | 181 | 148 | 136 |
| Capital work in progress | 0.00 | 0.00 | 0.80 | 39.32 | 10.15 | 1.31 | 5.95 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 |
| Inventories | 99.49 | 69.15 | 53.85 | 45.27 | 44.44 | 46.67 | 35.05 |
| Sundry debtors | 9.61 | 17.55 | 6.15 | 7.41 | 5.43 | 10.62 | 13.28 |
| Cash & bank balances | 12.85 | 11.40 | 50.59 | 61.54 | 57.80 | 32.56 | 5.04 |
| Loans & advances | 60.53 | 55.02 | 45.74 | 31.92 | 23.21 | 15.79 | 22.26 |
| Total current assets | 182 | 153 | 156 | 146 | 131 | 106 | 75.63 |
| Total current liabilities | 49.43 | 45.51 | 34.62 | 34.77 | 55.73 | 39.90 | 44.21 |
| Net working capital | 133 | 108 | 122 | 111 | 75.15 | 65.74 | 31.42 |
| Total assets | 436 | 401 | 418 | 334 | 252 | 202 | 165 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.58 | 0.27 | 4.04 | 0.07 | 0.32 | 0.77 | 0.13 |
| Net cash from operating activities | 21.65 | 10.81 | 17.95 | (0.04) | 59.37 | 27.16 | 21.56 |
| Net cash from investing activities | (1.85) | 32.88 | (81.53) | (50.68) | (73.55) | (42.86) | (7.54) |
| Net cash from financing activities | (19.97) | (43.38) | 59.81 | 54.69 | 13.93 | 15.25 | (13.37) |
| Net change in cash | (0.17) | 0.31 | (3.77) | 3.98 | (0.25) | (0.45) | 0.64 |
| Closing cash | 12.85 | 11.40 | 50.59 | 61.54 | 57.80 | 32.56 | 5.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +1.0% | -2.3% | +0.6% | +0.9% | +41.5% | -14.7% | - |
| EBITDA growth | +26.2% | +3.9% | -9.4% | -17.4% | +79.3% | -18.5% | - |
| PBT growth | +32.6% | -34.9% | -66.4% | -38.9% | +164.2% | -3.8% | +34.2% |
| Net income growth | +32.8% | +16.3% | -74.9% | -38.2% | +193.5% | -24.4% | - |
| Revenue CAGR (3Y) | -0.3% | -0.3% | +12.8% | +6.8% | +3.8% | -3.5% | +1.0% |
| EBITDA CAGR (3Y) | +5.9% | -8.0% | +10.3% | +6.5% | +17.6% | +6.4% | +8.8% |
| Profitability & leverage | |||||||
| Net income margin | +1.5% | +1.1% | +0.9% | +3.4% | +5.0% | +2.7% | +3.1% |
| Return on capital employed | +7.1% | +6.8% | +6.7% | +10.4% | +19.0% | +10.9% | +14.1% |
| Return on net worth | +3.8% | +3.0% | +2.4% | +9.8% | +18.3% | +6.8% | +11.3% |
| Debt / equity | 1.89 | 2.01 | 1.81 | 1.29 | 1.00 | 0.80 | 0.66 |
| Long-term debt / equity | 0.96 | 1.06 | 0.82 | 0.47 | 0.37 | 0.31 | 0.30 |
| Interest cover | 96.10 | 137.07 | 93.59 | 56.90 | 36.93 | 62.22 | 53.88 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.95 | 0.96 | 1.22 | 1.62 | 1.87 | 1.53 | 1.87 |
| Inventory turnover | 4.29 | 5.83 | 7.41 | 8.13 | 7.94 | 6.26 | 8.22 |
| Debtors turnover | 26.66 | 30.26 | 54.16 | 56.83 | 45.08 | 21.39 | 19.47 |
| EPS (βΉ) | 6.96 | 5.35 | 4.25 | 16.43 | 23.99 | 9.17 | 12.34 |
| Dividend per share (βΉ) | 0.50 | 0.50 | 1.00 | 2.50 | 2.50 | 2.00 | 1.00 |
| Book value per share (βΉ) | 188.83 | 181.60 | 176.79 | 174.62 | 160.62 | 138.09 | 129.80 |
Similar companies to Reliance Chemotex
Reliance Chemotex has 3 listed similar companies in our database, 2 of them funded. They include Gokaldas Exports, Eastman Exports and Shahi.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gokaldasexports.com | 1979 | Bengaluru, India | 7,111 | Apparel and clothing are manufactured and exported on contract. | ||
| eastmanexports.com | 2003 | Tiruppur, India | $57.97M | 4,956 | Apparel products are manufactured under contract in India. | |
| shahi.co.in | 1974 | Faridabad, India | $18.61M | 27,538 | Garments are contract-manufactured by Shahi in apparel production. |
Detailed similar companies of Reliance Chemotex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Reliance Chemotex
The website of Reliance Chemotex (reliancechemotex.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 35.7% vs previous month
Top companies in Contract & Outsourced Manufacturing
3 companies that operate in the same segment as Reliance Chemotex (Contract & Outsourced Manufacturing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Industrial components, mould bases, and storage solutions are manufactured globally. | 1986 | Coimbatore, Tamil Nadu, India | USD 28 M | USD 853.09 M | 43 | |
Single- and three-phase transformers are manufactured in Mumbai. | 1993 | Mumbai, Maharashtra, India | USD 114.37 M | 618 | ||
Apparel and clothing are manufactured and exported on contract. | 1979 | Bengaluru, Karnataka, India | USD 400 M | 40,280 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reliance Chemotex
Complete news archive for Reliance Chemotex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reliance Chemotex
Reliance Chemotex was founded in 1977.
Reliance Chemotex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Reliance Chemotex has 2,420 employees.
The primary company behind Reliance Chemotex, Reliance Chemotex Industries Ltd, reported revenue of βΉ366 Cr for FY 2026, up 1% year on year.
Reliance Chemotex is involved in the production of synthetic ecru and dyed yarns, catering to a wide range of textile industries globally. The companys products are utilized in applications such as carpets, awnings, artificial leather, and suitings. With exports to over 37 countries, operations are focused on quality and customer-centric solutions. The sector primarily served is textiles, with an emphasis on versatility and innovation in yarn manufacturing.
Reliance Chemotex's top competitors include Gokaldas Exports, Shahi and Eastman Exports.
Reliance Chemotex offers Synthetic Yarns.
Yes, Reliance Chemotex is publicly traded on NSE under the ticker symbol RELCHEMQ.
Reliance Chemotex operates through Reliance Chemotex Industries Ltd.
The legal entities of Reliance Chemotex currently have 8 directors, including Sanjiv Shroff, Rahul Shroff, Ameya Shroff and others.
